Diabetic Peripheral Neuropathy Archives | The Foundation for Peripheral Neuropathy

Highlights from the 2026 Peripheral Nerve Society Annual Meeting

Posted on July 24, 2026 (July 24, 2026) by Amanda Homscheid

The Foundation for Peripheral Neuropathy (FPN) is proud to have participated in the 2026 Peripheral Nerve Society (PNS) Annual Meeting in Maastricht, The Netherlands, alongside leading peripheral neuropathy (PN) researchers and clinicians from around the world. By engaging with the latest scientific discoveries and collaborating with experts across the field, FPN remains committed to bringing the most promising research developments in PN research and therapeutics to the neuropathy community.  […]

Neuropathy News Feb. 2026

Posted on February 12, 2026 (February 12, 2026) by Jane Bartmann

Critical funding restored for medical research After a huge cut in 2025, research funding for the Department of Defense’s Peer Reviewed Medical Research Program is finally back to its earlier level: $370 million.  This is great news for people living with peripheral neuropathy. Each year, we work hard to make sure PN is one of the topics that can receive this funding. The more […]

Neuropathy News Dec. 2025

Posted on December 9, 2025 (December 9, 2025) by Jane Bartmann

November was Diabetes Awareness Month Diabetes affects millions of people. It is a major cause of peripheral neuropathy. Last month, we shared information to help you understand how diabetes develops. We explained why it can damage nerves, and what you can do to stay healthy. Learning the signs early and managing blood sugar can lower […]

November is Diabetes Awareness Month

Posted on November 25, 2025 (November 25, 2025) by Jane Bartmann

Diabetes is the main cause of peripheral neuropathy. We’re supporting diabetes awareness month by promoting diabetes education. By learning about what can increase your risk of getting diabetes and the signs that show you might have it, you can take steps to prevent it or manage it better. And keeping your diabetes under control reduces […]

Neuropathy News Sept. 2025

Posted on September 9, 2025 (September 9, 2025) by Jane Bartmann

10 marathons. 26.2 miles. 1 mission. Please join us in celebrating PN patient and FPN friend Dieter’s incredible journey running Chicago 10 times! Now with a new purpose: raising awareness and funds for peripheral neuropathy. Diagnosed with idiopathic polyneuropathy in 2024, Dieter continues to run strong, proving that resilience and advocacy go hand in hand. Join […]

eNews November 2024

Posted on November 18, 2024 (February 18, 2025) by Becca Gilloway

November is Diabetes Awareness Month, a time dedicated to raising awareness about the causes, risks, and management of diabetes. As the leading cause of peripheral neuropathy, diabetes can have serious implications for nerve health. This month, we’re focusing on education and prevention strategies to help you reduce your risk or manage diabetes more effectively. […]

November is Diabetes Awareness Month

Posted on November 1, 2024 (February 11, 2025) by Becca Gilloway

eNews August 2024

Posted on August 18, 2024 (February 18, 2025) by Becca Gilloway

[…]

eNews July 2024

Posted on July 18, 2024 (February 18, 2025) by Becca Gilloway

FPN staff recently celebrated another terrific meeting in Montreal, Quebec, Canada, hosted by the Peripheral Nerve Society from June 22-25. Many research conversations took place, specifically concerning our biobank’s newest discoveries and an update on progress made towards the iMAGiNE Study research project that we fund. We look forward to sharing more details about new research underway in our upcoming […]

Join the NEPTUNE-17 clinical trial for Diabetic Peripheral Neuropathic Pain (DPNP)

Posted on July 11, 2024 (February 20, 2025) by Becca Gilloway

Does diabetic peripheral neuropathic pain (DPNP) disrupt your daily life and keep you awake at night despite your current treatment? You are not alone. The NEPTUNE-17 clinical trial, hosted by the Foundation for Peripheral Neuropathy Research Impact’s partner, GSK, offers a potential new option for managing DPNP symptoms. You may be eligible to participate in the trial if you: You will also need […]